Year: 2012

Construction work to affect Medical Center Drive

puzzel pieces, autism

Little evidence supports medical treatment options for adolescents with autism

Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population.

VU, Bristol-Myers to collaborate on Parkinson’s therapies

Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.

HER2 may impact lung cancer therapy

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

Wellons named chief of Pediatric Neurosurgery

The Department of Neurological Surgery has recruited John “Jay” Wellons III, M.D., MSPH, to serve as chief of Pediatric Neurosurgery.

Mchaourab to lead Chemical and Physical Biology program

Hassane Mchaourab, Ph.D., professor of Molecular Physiology & Biophysics, Physics and Chemistry, has been named the new director of the Ph.D.-granting Chemical and Physical Biology (CPB) program at Vanderbilt University.

1 19 20 21 22 23 51